Novartis FY2026 Earnings Forecast Raised by Erste Group Bank

Novartis AG (NYSE:NVS) – Equities researchers at Erste Group Bank lifted their FY2026 earnings estimates for Novartis in a research report issued on Thursday, October 8th. Erste Group Bank analyst H. Engel now expects that the company will post earnings of $9.24 per share for the year, up from their prior estimate of $9.14. The consensus estimate for Novartis’ current full-year earnings is $8.89 per share.

NVS has been the topic of a number of other research reports. The Goldman Sachs Group reiterated a “sell” rating on shares of Novartis in a research report on Monday, September 21st. JPMorgan Chase & Co. restated a “buy” rating on shares of Novartis in a research report on Sunday, August 9th. Royal Bank Of Canada initiated coverage on Novartis in a research note on Tuesday, September 8th. They set a “sector perform” rating for the company. Jefferies Financial Group reaffirmed a “neutral” rating on shares of Novartis in a research note on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “neutral” rating on shares of Novartis in a research report on Thursday, September 17th. Six analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Novartis currently has a consensus rating of “Hold” and an average target price of $145.60.

Novartis Price Performance

Shares of Novartis stock opened at $143.85 on Tuesday. The firm has a market cap of $274.49 billion, a PE ratio of 21.70, a P/E/G ratio of 2.74 and a beta of 0.41. Novartis has a twelve month low of $121.57 and a twelve month high of $170.46. The company has a quick ratio of 0.67, a current ratio of 0.86 and a debt-to-equity ratio of 0.89. The business has a 50-day moving average price of $148.91 and a 200 day moving average price of $150.53.

Novartis (NYSE:NVS) last issued its quarterly earnings data on Tuesday, June 30th. The company reported $2.41 earnings per share for the quarter. The business had revenue of $14.95 billion during the quarter. Novartis had a net margin of 23.29% and a return on equity of 38.56%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NVS. Woodstock Corp lifted its position in shares of Novartis by 21.4% during the 3rd quarter. Woodstock Corp now owns 3,407 shares of the company’s stock worth $486,000 after buying an additional 600 shares during the last quarter. JGP Wealth Management LLC raised its stake in Novartis by 13.4% during the 3rd quarter. JGP Wealth Management LLC now owns 2,847 shares of the company’s stock worth $406,000 after acquiring an additional 336 shares in the last quarter. HF Advisory Group LLC lifted its position in Novartis by 4.0% in the third quarter. HF Advisory Group LLC now owns 8,897 shares of the company’s stock valued at $1,268,000 after acquiring an additional 346 shares during the last quarter. GK Wealth Management LLC purchased a new stake in Novartis in the third quarter valued at $146,000. Finally, Wedmont Private Capital boosted its stake in Novartis by 50.8% in the third quarter. Wedmont Private Capital now owns 8,890 shares of the company’s stock valued at $1,272,000 after acquiring an additional 2,996 shares in the last quarter. Hedge funds and other institutional investors own 13.12% of the company’s stock.

About Novartis

Novartis AG is a Switzerland-based pharmaceutical company focused on the discovery, development and commercialization of innovative medicines. The company’s research and commercial activities center on cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology and hematology. Its portfolio includes prescription medicines such as Entresto, Cosentyx, Kesimpta, Kisqali, Pluvicto, Leqvio and Jakavi, as well as other therapies for serious and chronic conditions.

Novartis serves patients and healthcare providers in markets worldwide, with operations spanning North America, Europe, Asia and other international regions.